1. Home
  2. EVLV vs ANL Comparison

EVLV vs ANL Comparison

Compare EVLV & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$4.06

Market Cap

994.7M

Sector

Technology

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.83

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
ANL
Founded
2013
2004
Country
United States
Singapore
Employees
N/A
N/A
Industry
Computer peripheral equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
994.7M
998.8M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
EVLV
ANL
Price
$4.06
$10.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$9.85
★ $29.50
AVG Volume (30 Days)
★ 2.1M
235.2K
Earning Date
11-10-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.18
N/A
EPS
N/A
★ N/A
Revenue
★ $145,905,000.00
N/A
Revenue This Year
$25.01
$243.83
Revenue Next Year
$20.02
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 40.48
N/A
52 Week Low
$4.02
$0.88
52 Week High
$8.40
$17.25

Technical Indicators

Market Signals
Indicator
EVLV
ANL
Relative Strength Index (RSI) 23.98 30.35
Support Level N/A $8.96
Resistance Level $5.86 $12.49
Average True Range (ATR) 0.15 1.37
MACD -0.04 -0.51
Stochastic Oscillator 4.47 1.73

Price Performance

Historical Comparison
EVLV
ANL

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc is a security technology company pioneering Artificial Intelligence (AI)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. It serves customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. The company operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: